Almost immediately after the severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) virus emerged, it was evident that people with chronic diseases, including diabetes, were …
Background There are concerns that the response to the COVID-19 pandemic in the UK might have worsened physical and mental health, and reduced use of health services …
AK Singh, K Khunti - Annual review of medicine, 2022 - annualreviews.org
The prevalence of diabetes in people with coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has varied worldwide …
B Godman, A Egwuenu, E Wesangula… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Antimicrobial resistance (AMR) is a concern as this increases morbidity, mortality, and costs, with sub-Saharan Africa having the highest rates globally. Concerns …
K Khunti, VR Aroda, P Aschner, JCN Chan… - The Lancet Diabetes & …, 2022 - thelancet.com
The COVID-19 pandemic has disproportionately affected certain groups, such as older people (ie,> 65 years), minority ethnic populations, and people with specific chronic …
DH Jiang, DJ Roy, BJ Gu, LC Hassett… - Basic to Translational …, 2021 - jacc.org
The vast majority of patients (> 99%) with severe acute respiratory syndrome coronavirus 2 survive immediate infection but remain at risk for persistent and/or delayed multisystem. This …
OBJECTIVE To determine the respective associations of premorbid glucagon-like peptide-1 receptor agonist (GLP1-RA) and sodium–glucose cotransporter 2 inhibitor (SGLT2i) use …
COVID-19 pandemic has been a major global issue, its eventual influences on the population welfare, global markets, public security, and everyday activities remain uncertain …
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the ADA's current clinical practice recommendations and is intended to provide the components …